STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #1378 by analyst upside · 2026-06-27
SGHT
Sight Sciences, Inc.
Healthcare · Market Cap $310M · P/E 0x
ANALYST PRICE TARGET
+50.0%
implied upside to consensus target
Current Price $5.69
Consensus Target $8.54
Bull Target $12.0
Bear Target $5.15
Analysts Covering 4
ANALYST CONSENSUS - BUY
Strong Buy
1
Buy
2
Hold
1
Sell
0
52-Week Low $3.11
52-Week High $9.24
YTD Return -23.9%
FUNDAMENTALS
Market Cap $310M
P/E Ratio (TTM) N/A
Forward P/E -8.6x
EPS (TTM) $-0.73
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $80M
Profit Margin -46.8%
52-WEEK RANGE
52-Week Low $3.11
52-Week High $9.24
Current Price $5.69
Bear Target $5.15
Bull Target $12.0
● Now $5.69 ● Target $8.54
TRADING DATA
Avg Volume 245K
YTD Return -23.9%
Analyst Count 4
Consensus Buy
Upside to Target +50.0%
Last Updated 2026-06-27

ANALYST SUMMARY

Sight Sciences, Inc. (SGHT) is currently trading at $5.69 with a Wall Street consensus price target of $8.54, implying potential upside of 50.0% over the next 12 months. 4 analysts currently cover SGHT, with a consensus rating of Buy - 75% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $12.0, while the most cautious has a target of $5.15.

SGHT operates in the Healthcare sector with a market capitalisation of $310M. The stock is down 23.9% year-to-date and is currently trading near the lower end of its 52-week range of $3.11 – $9.24.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for SGHT, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Citigroup — Reiterated
Neutral → Neutral 2026-05-28 Building track record
UBS — Reiterated
Buy → Buy 2026-03-06 33% win rate (6 calls)
Citigroup — Reiterated
Neutral → Neutral 2026-03-06 Building track record
Stifel — Reiterated
Buy → Buy 2026-03-02 Building track record
Piper Sandler ↑ Upgrade
Neutral → Overweight 2026-01-05 14% win rate (7 calls)
UBS — Reiterated
Buy → Buy 2025-12-23 33% win rate (6 calls)
Citigroup — Reiterated
Neutral → Neutral 2025-12-11 Building track record
Lake Street — Reiterated
Buy → Buy 2025-12-10 27% win rate (11 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
32
out of 100
Coverage depth
12/30
Consensus clarity
6/30
Vote unanimity
12/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →